跳转至内容
Merck
所有图片(1)

Key Documents

EMU043701

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Lrpprc

登录查看公司和协议定价
所有图片(1)

About This Item

分類程式碼代碼:
41105324
NACRES:
NA.51

描述

Powered by Eupheria Biotech

產品線

MISSION®

形狀

lyophilized powder

esiRNA cDNA 標靶序列

GAGCTGCTTTGCAGGAAAATGAATGTCTCCTCGCAAGTAGTACCTTTGCTCAAGCTGAAGTGAAGAATGAAGCAATAAATGGGAACTTACAGAACATTTTGTCATTTTTGGAATCGAATACATTACCTTTCTCGTTTAGTTCTTTGAGAAACAGCCTAATCCTAGGCTTCAGGAGGTCGATGAACATAGATCTTTGGAGCAAGATAACAGAATTGTTGTACAAGGATGAACGCTATTGCTCAAAGCCTCCGGGACCAGCGGAAGCTGTTGGCTATTTTCTTTATAACTTGATTGACAGCATGAGTGACTCAGAGGTACAGGCCAAGGAGGAGCGTTTGAGACAATACTTCCATCAGCTGCAGGAGATGAATGTTAAAGTTCCTGAAAACATCTACAAAGGCATTTGTAATTTGCTGAATACCTACCATGTTCCTGAATTGATTAAGGATATTAAGGTTCTGGTTGACAGAGAGAAGGTAGATTCTCAAAAAACTTCTCAAGTTACCTCATCTGATTTGGAATCAACACTTGAGAAACTCAAAGCTGAAGGCCA

Ensembl | 小鼠類登錄號

ENSMUSG00000024120

NCBI登錄號

NM_028233

運輸包裝

ambient

儲存溫度

−20°C

基因資訊

mouse ... LRPPRC(72416) , Lrpprc(72416)

一般說明

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法律資訊

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

10 - Combustible liquids

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Stephany Corrêa et al.
Epigenetics, 9(8), 1172-1183 (2014-08-05)
One of the potential mechanisms of imatinib mesylate (IM) resistance in chronic myeloid leukemia (CML) is increased level of P-glycoprotein (Pgp). Pgp is an efflux pump capable of activating the multidrug resistance (MDR) phenotype. The gene encoding Pgp (ABCB1) has
Keiko Fujimoto et al.
Molecular pharmacology, 88(4), 660-675 (2015-07-17)
Tocilizumab (TCZ), a humanized anti-interleukin-6 (IL-6) receptor (IL-6R) monoclonal antibody, abrogates signal transducer protein gp130-mediated IL-6 signaling by competitively inhibiting the binding of IL-6 to the receptor, and shows clinical efficacy in autoimmune and inflammatory diseases. Despite accumulating evidence for

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门